MEDPRO SYSTEMS
Live / Registered — Registered (as of 02 Jul 2024)
What this means for you
Registered since 02 Jul 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98048406
- Registration number
- 7432933
- Mark type
- Design + words
- Filed
- 19 Jun 2023
- Published for opposition
- 16 Apr 2024
- Registered
- 02 Jul 2024
- Attorney of record
- Christine Amara
Goods and services
- Class 035 — Advertising and business services: Business consulting services for life sciences, pharmaceuticals, biotechnology and medical device companies in the nature of regulatory compliance program development and enhancement and transparency program support, namely, reviewing program status and performing gap analyses, drafting programs plans, program implementation support, development and improvement of policies, standard operating procedures and codes of conduct; business consulting services in the nature of monitoring of pharmaceutical and medical device manufacturer interactions with healthcare professionals, healthcare organizations, patients, and other customers; business consulting services in the nature of auditing of pharmaceutical and medical device manufacturer interactions with and payments to healthcare professionals, healthcare organizations, patients, and other customers; business consulting services in the nature of business investigation support for internally and externally raised complaints made against a pharmaceutical or medical device manufacturer related to potential violations of their company policy or code, industry code, or law or regulation; transparency reporting regulatory submission management, namely, assisting others in preparing and filing regulatory submissions in the field of transparency reporting for pharmaceutical, biotechnology and medical device companies; business consulting services, namely, tracking and monitoring regulatory requirements for others in the field of life sciences, pharmaceuticals, biotechnology, and medical devices for regulatory compliance; business consulting services, namely, compliance program gap analysis for life sciences, pharmaceutical, biotechnology, and medical device companies
- Class 041 — Education and entertainment services: Consulting services in the nature of conducting trainings for life sciences, pharmaceuticals, biotechnology, and medical device companies personnel and partners on pharmaceutical and medical device compliance program requirements, fraud and corruption laws and regulations, industry codes and best practices; consulting services, namely, developing and providing trainings for life sciences, pharmaceutical, biotechnology, and medical device companies in the field of corporate compliance and transparency programs
- Class 042 — Scientific and technological services: Software as a service (SaaS) services featuring software for use to assist in tracking and reporting healthcare practitioner and healthcare organization interactions and complying with international, federal, state and local spend and transparency laws and regulations; software as a service (SaaS) services featuring software to assist pharmaceutical, biotechnology and medical device companies in managing, validating and enriching healthcare organization and healthcare practitioner data attributes in connection with regulatory compliance, sales and marketing efforts
- Class 045 — Legal and security services: Regulatory compliance consulting in the field of life sciences, pharmaceuticals, biotechnology, and medical devices; consulting services to assist life sciences, pharmaceutical, biotechnology and medical device companies in the fields of regulatory compliance, namely, compliance in the areas of aggregate spend disclosure reporting, the Prescription Drug Marketing Act, the Drug Supply Chain Security Act, Condition of Participation for Outpatient Services, Stark Law and Ohio Terminal Distributor of Dangerous Drugs requirements; regulatory compliance audits for life sciences, pharmaceutical, biotechnology and medical device companies to assist with regulatory compliance; consulting services in the field of life sciences, pharmaceutical, biotechnology and medical device corporate compliance program and transparency program development, implementation and support; providing online searchable databases and information concerning historical, current and pending laws, regulations, and guidance documents governing the life sciences industry; regulatory compliance consulting services in the field of aggregate spend disclosure reporting; regulatory and compliance information for pharmaceutical, biotechnology and medical device companies, and for entities involved in the drug and device supply chain, regarding transparency and aggregate spend, marketing, and additional compliance requirements; regulatory compliance consulting, namely, reviewing, developing, training on and assisting with the implementation and monitoring of standards, practices, procedures and policies to support regulatory compliance for companies in the fields of life sciences, pharmaceuticals, biotechnology, and medical devices
Owner
- MedPro Systems LLC, Mt. Arlington, NJ, US
- MedPro Systems LLC, Mt. Arlington, NJ, US
- MedPro Systems LLC, Mt. Arlington, NJ, US
Prosecution history
- 02 Jul 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Jul 2024 — REGISTERED-PRINCIPAL REGISTER
- 16 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Apr 2024 — PUBLISHED FOR OPPOSITION
- 27 Mar 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Mar 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Mar 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Mar 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Mar 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 01 Mar 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 01 Mar 2024 — NON-FINAL ACTION E-MAILED
- 01 Mar 2024 — NON-FINAL ACTION WRITTEN
- 26 Feb 2024 — ASSIGNED TO EXAMINER
- 22 Jul 2023 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 21 Jul 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED